OTC Markets OTCPK - Delayed Quote USD

Guardion Health Sciences, Inc. (GHSI)

3.2200

0.0000

(0.00%)

At close: April 25 at 4:00:00 PM EDT

Guardion Health Sciences Announces Declaration of Cash Distribution

HOUSTON, TEXAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash distribution (the “Distribution”) in an amount equal to $3.25 per share of common stock, par value $0.001 per share (the “Common Stock”), held by the Company’s stockholders of record on October 30, 2024, which was the effective date of the Company’s previously-announced legal dissolution. The Company expects to pay the Distribu

GlobeNewswire 4 months ago

GHSI
0.00%
Guardion Health Sciences Announces Filing of Certificate of Dissolution

HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that it has filed a certificate of dissolution with the Secretary of State of the State of Delaware, which became effective upon filing on October 30, 2024 (the “Effective Date”). The filing of the certificate was made pursuant to the terms of the Company’s Plan of Liquidation and Dissolution (the “Plan”) approved by stockholders at the Company’s special m

GlobeNewswire 5 months ago

GHSI
0.00%
Guardion Health Sciences Announces Delisting and New Interim CEO

Guardion Health Sciences ( (GHSI) ) has issued an announcement. Guardion Health Sciences, Inc. has initiated a significant corporate shakeup, announcing both the delisting of its common stock from the Nasdaq Capital Market and the appointment of Mark Goldstone as the Interim President and CEO, effective October 18, 2024. This move comes as part of a larger dissolution and liquidation plan following the sale of its Viactiv® brand. Goldstone, with over two decades of healthcare industry experience

TipRanks 6 months ago

GHSI
0.00%
Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO

Plan includes Voluntary Delisting of Common Stock from Nasdaq and Suspension of SEC Reporting Obligations HOUSTON, TEXAS, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that it has notified the Nasdaq Stock Market (“Nasdaq”) of its intent to delist its common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Capital Market. Guardion expects to file a Form 25 (Notification of Removal from Listing)

GlobeNewswire 6 months ago

GHSI
0.00%
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash dividend in an amount equal to $5.00 per share of common stock held by its stockholders of record on September 9, 2024 and a payment date of September 23, 2024. Forward-Looking Statements The matters described herein may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act

GlobeNewswire 8 months ago

GHSI
0.00%
Guardion Health Sciences Second Quarter 2024 Earnings: US$1.66 loss per share (vs US$0.93 loss in 2Q 2023)

Guardion Health Sciences ( NASDAQ:GHSI ) Second Quarter 2024 Results Key Financial Results Revenue: US$72.9k (down 97...

Simply Wall St. 8 months ago

GHSI
0.00%
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024

Guardion Also Provides an Update to Stockholders of Significant Recent Developments HOUSTON, TEXAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers science-based, clinically supported products designed for consumer ocular health, today announced its financial results for the three months and six months ended June 30, 2024, as described below. The Company also provided an update to stockholders

GlobeNewswire 8 months ago

GHSI
0.00%
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution

HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced that today it closed on its Definitive Agreement to sell its Viactiv business to Doctor’s Best Inc. for gross cash consideration of $17,200,000. The Comp

GlobeNewswire 10 months ago

GHSI
0.00%
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

Adjourns Special Meeting to May 31, 2024 in order to Solicit Additional Proxies in Support of its Plan of Liquidation and Dissolution HOUSTON, TEXAS, May 23, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced today that its stoc

GlobeNewswire 10 months ago

GHSI
0.00%
Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024

Company Estimates the Aggregate Potential Liquidating Distributions to Range from approximately $9.00 to $11.00 per Share if Stockholders Vote to Approve the Sale of the Company’s Viactiv Business and the Plan of Liquidation and Dissolution HOUSTON, TEXAS, May 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health n

GlobeNewswire 11 months ago

GHSI
0.00%
Guardion Health Sciences Announces

-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at the Upcoming Special Meeting of Stockholders on May 23, 2024 Board of Directors Urges Stockholders to Vote to Approve the Sale of the Company’s Viactiv Brand and Business and Plan of Liquidation and Dissolution If both proposals are approved, stockholders would receive one or more liquidating cash distrib

GlobeNewswire 11 months ago

GHSI
0.00%

Performance Overview

Return	GHSI	S&P 500 (^GSPC)
YTD	--	-6.06%
1-Year	+6,093.22%	+9.44%
3-Year	+5,486.51%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Guardion Health Sciences, Inc. (GHSI)

Guardion Health Sciences Announces Declaration of Cash Distribution

Guardion Health Sciences Announces Filing of Certificate of Dissolution

Guardion Health Sciences Announces Delisting and New Interim CEO

Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO

Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

Guardion Health Sciences Second Quarter 2024 Earnings: US$1.66 loss per share (vs US$0.93 loss in 2Q 2023)

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024

Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution

Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024

Guardion Health Sciences Announces

Performance Overview